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Abstract
Background: It has recently been suggested that RhoA plays an important role in the
enhancement of the Ca2+ sensitization of smooth muscle contraction. In the present study, a
participation of RhoA-mediated Ca2+ sensitization in the augmented bronchial smooth muscle
(BSM) contraction in a murine model of allergic asthma was examined.
Methods: Ovalbumin (OA)-sensitized BALB/c mice were repeatedly challenged with aerosolized
OA and sacrificed 24 hours after the last antigen challenge. The contractility and RhoA protein
expression of BSMs were measured by organ-bath technique and immunoblotting, respectively.
Results: Repeated OA challenge to sensitized mice caused a BSM hyperresponsiveness to
acetylcholine (ACh), but not to high K+-depolarization. In α-toxin-permeabilized BSMs, ACh
induced a Ca2+ sensitization of contraction, which is sensitive to Clostridium botulinum C3
exoenzyme, indicating that RhoA is implicated in this Ca2+ sensitization. Interestingly, the ACh-
induced, RhoA-mediated Ca2+ sensitization was significantly augmented in permeabilized BSMs of
OA-challenged mice. Moreover, protein expression of RhoA was significantly increased in the
hyperresponsive BSMs.
Conclusion: These findings suggest that the augmentation of Ca2+ sensitizing effect, probably via
an up-regulation of RhoA protein, might be involved in the enhanced BSM contraction in antigen-
induced airway hyperresponsiveness.
Background
Increased airway narrowing in response to nonspecific
stimuli is a characteristic feature of human obstructive dis-
eases, including bronchial asthma. This abnormality is an
important symptom of the disease, although the patho-
physiological variations leading to the hyperresponsive-
ness are unclear now. Several mechanisms have been
suggested to explain the airway hyperresponsiveness
(AHR), such as alterations in the neural control of airway
smooth muscle [1], increased mucosal secretions [2], and
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[3]. In addition, it has also been suggested that one of the
factors that contribute to the exaggerated airway narrow-
ing in asthmatics is an abnormality of the nature of airway
smooth muscle [4,5]. Rapid relief from airway limitation
in asthmatic patients by β-stimulant inhalation may also
suggest an involvement of augmented airway smooth
muscle contraction in the airway obstruction. Thus, it may
be important for development of asthma therapy to
understand changes in the contractile signaling of airway
smooth muscle cells associated with the disease.
Smooth muscle contraction including airways is mainly
regulated by an increase in cytosolic Ca2+ concentration in
myocytes. Recently, additional mechanisms have been
suggested in agonist-induced smooth muscle contraction
by studies in which the simultaneous measurements of
force development and intracellular Ca2+ concentration,
and chemically permeabilized preparations in various
types of smooth muscles were used. It has been demon-
strated that agonist stimulation increases myofilament
Ca2+ sensitivity in permeabilized smooth muscles of the
rat coronary artery [6], guinea pig vas deferens [7], canine
trachea [8] and rat bronchus [9]. Although the detailed
mechanism is not fully understood, a participation of
RhoA, a monomeric GTP binding protein, in the agonist-
induced Ca2+ sensitization has been suggested by many
investigators [10]. Moreover, an augmented RhoA-medi-
ated Ca2+ sensitization in smooth muscle contraction has
been reported in experimental animal models of diseases
such as hypertension [11-13], coronary [14-16] and cere-
bral [17-19] vasospasm. It is thus possible that RhoA-
mediated signaling is the key for understanding the
abnormal contraction of diseased smooth muscles.
Here, we show an increased acetylcholine (ACh)-induced
contraction of bronchial smooth muscle (BSM) isolated
from repeatedly ovalbumin (OA)-challenged BALB/c
mice, which have been reported to have in vivo AHR [20].
A participation of RhoA-mediated Ca2+ sensitization in
the augmented ACh-induced contraction of BSM was
demonstrated in this animal model of AHR.
Methods
Sensitization and antigenic challenge
Male BALB/c mice (6-week old, specific pathogen-free;
Charles River Japan, Inc., Kanagawa, Japan) were used. All
experiments were approved by the Animal Care Commit-
tee at the Hoshi University (Tokyo, Japan). Preparation of
a murine model of allergic bronchial asthma, which has
in vivo airway hyperresponsiveness (AHR), was per-
formed as described by Kato et al. [20]. In brief, mice were
actively sensitized by intraperitoneal injections of 8 µg
ovalbumin (OA; Seikagaku Co., Tokyo, Japan) with 2 mg
Imject Alum (Pierce Biotechnology, Inc., Rockfold, IL,
USA) on day 0 and day 5. The sensitized mice were chal-
lenged with aerosolized OA-saline solution (5 mg/ml) for
30 min on days 12, 16 and 20. A control group of mice
received the same immunization procedure but inhaled
saline aerosol instead of OA challenge. The aerosol was
generated with an ultrasonic nebulizer (Nihon Kohden,
Tokyo, Japan) and introduced to a Plexiglas chamber box
(130 × 200 mm, 100 mm height) in which the mice were
placed.
Determination of intact bronchial smooth muscle (BSM) 
responsiveness
Twenty-four h after the last antigen challenge, the mice
were sacrificed by exsanguination from abdominal aorta
under urethane (1.6 g/kg, i.p.) anesthesia. Then the airway
tissues under the larynx to lungs were immediately
removed. About 3 mm length of the left main bronchus
(about 0.5 mm diameter) was isolated and epithelium
was removed by gently rubbing with keen-edged tweezers
[21]. The resultant tissue ring preparation was then sus-
pended in a 5 ml-organ bath by two stainless-steel wires
(0.2 mm diameter) passed through the lumen. For all tis-
sues, one end was fixed to the bottom of the organ bath
while the other was connected to a force-displacement
transducer (TB-612T, Nihon Kohden) for the measure-
ment of isometric force. A resting tension of 0.5 g was
applied. The buffer solution contained modified Krebs-
Henseleit solution with the following composition (mM);
NaCl 118.0, KCl 4.7, CaCl2 2.5, MgSO4 1.2, NaHCO3
25.0, KH2PO4 1.2 and glucose 10.0. The buffer solution
was maintained at 37°C and oxygenated with 95% O2-5%
CO2. The BSM responsiveness to exogenously applied
Ca2+ in acetylcholine (ACh)-stimulated or high K+-depo-
larized muscle was determined as previously [22]. In brief,
after an equilibration period, the organ bath solution was
replaced with Ca2+-free solution containing 10-6 M nica-
rdipine with the following composition (mM); NaCl
122.4, KCl 4.7, MgSO4 1.2, NaHCO3 25.0, KH2PO4 1.2,
glucose 10.0 and EGTA 0.05. Fifteen min later, 1 mM ACh
was added and, after attainment of a plateau (almost base-
line level) response to ACh, a cumulative concentration-
response curve for Ca2+ (0.1–6.0 mM) was made. A higher
concentration of Ca2+ was added after the response to the
previous concentration reached a plateau. In another
series of experiments, bronchial smooth muscles were
depolarized with 60 mM K+, instead of ACh, in the pres-
ence of 10-6 M atropine and in the absence of nicardipine
in the Ca2+-free solution. All these functional studies were
performed in the presence of 10-6 M indomethacin. The
concentration of indomethacin had no effect both on
baseline tension and on the ACh- and high K+-induced
constrictions of BSMs (data not shown).Page 2 of 11
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To determine the change in Ca2+ sensitization of BSM con-
traction, permeabilized BSMs were prepared as described
previously [21] with minor modification. In brief, 24 h
after the last antigen challenge, the left main bronchus
was isolated as described above and cut into ring strips
(about 200 µm width, 500 µm diameter). The epithelium
was removed by gently rubbing with keen-edged tweezers.
The ring strips were then permeabilized by a 30-min treat-
ment with 83.3 µg/ml α-toxin (Sigma, St. Louis, MO,
USA) in the presence of Ca2+ ionophore A23187 (10 µM,
Sigma) at room temperature in relaxing solution. Relaxing
solution contained: 20 mM PIPES, 7.1 mM Mg2+-dimeth-
anesulfonate, 108 mM K+-methanesulfonate, 2 mM
EGTA, 5.875 mM Na2ATP, 2 mM creatine phosphate, 4 U/
ml creatine phosphokinase, 1 µM carbonyl cyanide p-trif-
luoromethoxyphenylhydrazone (FCCP) and 1 µg/ml E-
64 (pH 6.8) containing 10 µM A23187. Free Ca2+ concen-
tration was changed by adding an appropriate amount of
CaCl2. The apparent binding constant of EGTA for Ca2+
was considered to be 106 M-1 [23]. The permeabilized
muscle strip was then suspended in a 400-µL organ bath
at room temperature. The contractile force developed was
measured by an isometric transducer (T7-8-240; Orientec,
Tokyo, Japan) under a resting tension of 50 mg. To deter-
mine the involvement of RhoA in the ACh-induced myo-
filament Ca2+ sensitization, the α-toxin-permeabilized
muscle strips were treated with Clostridium botulinum C3
exoenzyme (10 µg/ml; Calbiochem-Novabiochem Corp.,
La Jolla, CA) in the presence of 100 µM NAD for 20 min
at room temperature.
Determination of RhoA protein level in BSM
Protein samples of BSMs were prepared as previously [21].
In breif, the airway tissues below the main bronchi to
lungs were removed and immediately soaked in ice-cold,
oxygenated Krebs-Henseleit solution. The airways were
carefully cleaned of adhering connective tissues, blood
vessels and lung parenchyma under a stereomicroscopy.
The epithelium was removed as much as possible by gen-
tly rubbing with keen-edged tweezers [21]. Then the bron-
chial tissue (containing the main and intrapulmonary
bronchi) segments were quickly frozen with liquid nitro-
gen, and the tissue was crushed to pieces by CryopressTM
(CP-100W; Microtec, Co. Ltd., Chiba, Japan: 15 sec × 3).
The tissue powder was homogenized in ice-cold
tris(hydroxymethyl)aminomethane (Tris, 10 mM; pH
7.5) buffer containing 5 mM MgCl2, 2 mM EGTA, 250
mM sucrose, 1 mM dithiothreitol, 1 mM 4-(2-aminoe-
thyl)benzenesulfonyl fluoride, 20 µg/ml leupeptin, 20
µg/ml aprotinin, 1% Triton X-100 and 1% sodium cho-
late. The tissue homogenate was then centrifuged (3,000
g, 4°C for 15 min) and the resultant supernatant was
stored at -85°C until use. To determine the level of RhoA
protein in BSMs, the samples (10 µg of total protein per
lane) were subjected to 15% SDS-PAGE and the proteins
were then electrophoretically transferred to a PVDF mem-
brane. After blocking with 3% gelatin, the PVDF mem-
brane was incubated with polyclonal rabbit anti-RhoA
antibody (1:3,000; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA). Then the membrane was incubated with
horseradish peroxidase-conjugated goat anti-rabbit IgG
(1:2,500 dilution; Amersham Biosciences, Co., Piscata-
way, NJ, USA), detected by an enhanced chemilumines-
cent system (Amersham Biosciences, Co.) and analyzed
by a densitometry system. Thereafter, the primary and sec-
ondary antibodies were stripped and the membrane was
reprobed by using monoclonal mouse anti-glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH; 1:3,000 dilu-
tion; Chemicon International, Inc., Temecula, CA, USA)
to confirm the same amount of proteins loaded.
Determination of active form of RhoA in BSM
The active form of RhoA, GTP-bound RhoA, in BSMs was
measured by RhoA pull down assay. In brief, bronchial
tissues containing the main and intrapulmonary bronchi
were isolated as described above. The isolated bronchial
tissues were equilibrated in oxygenated Krebs-Henseleit
solution at 37°C for 1 hr. After the equilibration period,
the tissues were stimulated by ACh (10-3 M for 10 min)
and were quickly frozen with liquid nitrogen. The tissues
were then lysed in lysis buffer with the following compo-
sition (mM); HEPES 25.0 (pH 7.5), NaCl 150, IGEPAL
CA-630 1%, MgCl2 10.0, EDTA 1.0, glycerol 10%, NaF
25.0, sodium orthovanadate 1.0 and peptidase inhibitors.
Active RhoA in tissue lysates (200 µg protein) was precip-
itated with 25 µg GST-tagged Rho binding domain
(amino acids residues 7–89 of mouse rhotekin; Upstate,
Lake Placid, NY, USA), which was expressed in Escherichia
coli and bound to glutathione-agarose beads. The precipi-
tates were washed three times in lysis buffer, and after
adding the SDS loading buffer and boiling for 5 min, the
bound proteins were resolved in 15% polyacrylamide
gels, transferred to nitrocellulose membranes, and immu-
noblotted with anti-RhoA antibody as described above.
Determination of phosphorylation of myosin phosphatase 
and myosin light chain in BSM
Phosphorylated proteins were detected by using the fluo-
rescent Pro-Q-Diamond dye (Molecular Probes, Eugene,
OR, USA), which can directly detect phosphate groups
attached to tyrosine, serine or threonine residues in gels
[24]. In brief, bronchial tissue lysates (50 µg protein) with
SDS loading buffer prepared as described above were
resolved in 10 – 20% gradient polyacrylamid gels (Atto
Co., Tokyo, Japan). Proteins were fluorescently stained by
fixing the gels in 50% methanol and 10% acetic acid for 1
h. The gels were washed with deionised water for 20 min,
stained with Pro-Q-Diamond for 1.5 h and destained by
three washes in 4% acetonitrile in 50 mM sodium acetate,Page 3 of 11
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Typhoon 9410 laser scanner (Amersham Biosciences,
Co.), with excitation at 532 nm and a 580 nm band pass
emission filter for Pro-Q-diamond dye detection. Phos-
phorylated proteins were quantified densitometrically
with the ImageQuant software (Amersham Biosciences,
Co.). After scanning, the gels were washed with deionised
water for 30 min and incubated in 0.7% glycine-0.2% SDS
in 0.3% Tris buffer for 15 min. The proteins were then
electrophoretically transferred to a PVDF membrane and
immunoblottings for myosin phosphatase target subunit
1 (MYPT1; polyclonal goat anti-MYPT1 antibody; 1:1000;
Santa Cruz Biotechnology, Inc.), GAPDH and myosin
light chain (MLC; polyclonal rabbit anti-MLC2 antibody;
1:3000; Santa Cruz Biotechnology, Inc) were performed
as described above.
Statistical analyses
All the data are expressed as the mean ± S.E. Statistical sig-
nificance of difference was determined by unpaired Stu-
dent's t-test, Bonferroni/Dunn's test or two-way analysis
of variance (ANOVA).
Results
Contractile response of intact BSM preparations
Under Ca2+-free condition (in the presence of 10-6 M nica-
rdipine and 0.05 mM EGTA), ACh (10-3 M) generated a
transient phasic contraction in all BSM preparations used.
The generated tension of BSM from the repeatedly OA-
challenged mice (69 ± 12 mg, N = 6) was significantly
greater than that from the sensitized control animals (20
± 12 mg, N = 6; P < 0.05). The concentration of nica-
rdipine used in the present study completely blocked high
K+ (10–90 mM)-induced BSM contraction in Ca2+ (2.5
mM) containing normal Krebs-Henseleit solution (data
not shown), indicating that voltage-dependent Ca2+ chan-
nels were completely blocked in this condition.
The tension returned to baseline level within 5 min after
the ACh application, and then the contraction induced by
cumulatively administered Ca2+ was measured. Figure 1A
shows the concentration-response curves to Ca2+ of
murine BSMs that were preincubated with nicardipine
(10-6 M) and ACh (10-3 M) under Ca2+-free (0.05 mM
EGTA) condition. Addition of Ca2+ induced a concentra-
tion-dependent BSM contraction in both the sensitized
control and OA-challenged groups. The contractile
response to Ca2+ of the ACh-stimulated BSMs from the
repeatedly OA-challenged mice was markedly augmented
as compared to that from the sensitized control animals.
By contrast, no significant difference in the response to
Ca2+ of BSMs depolarized with 60 mM K+ (in the absence
of nicardipine and presence of 10-6 M atropine) was
observed between groups (Fig. 1B). Likewise, the ACh (10-
7–10-3 M) concentration-response curve determined in
normal Krebs-Henseleit solution (2.5 mM Ca2+) was sig-
nificantly shifted upward in BSMs from the OA-chal-
lenged mice as compared with that from the sensitized
control animals, whereas no significant difference in the
contractile response induced by isotonic high K+ (10–90
mM) was observed between groups (data not shown).
Contractile response of α-toxin-permeabilized BSM 
preparations
The BSM contractility was also determined by using α-
toxin-permeabilized BSM preparations. In all BSM prepa-
rations treated with a-toxin, application of free Ca2+ (pCa
= 6.5, 6.3, 6.0, 5.5 and 5.0) induced a concentration-
dependent reproducible contractile response, indicating
successful permeabilization. In the α-toxin-permeabilized
BSM, no significant difference in the Ca2+ responsiveness
or the maximal contractile response induced by pCa 5.0
(Emax) was observed between the sensitized control
(pEC50[Ca2+ (M)] = 5.67 ± 0.04, Emax = 26.7 ± 1.2 mg; N
= 6) and repeatedly OA-challenged (pEC50[Ca2+ (M)] =
5.78 ± 0.15, Emax = 22.8 ± 5.9 mg; N = 6) groups. In both
groups, when the Ca2+ concentration was clamped at pCa
6.0, application of ACh (10-5–10-3 M) in the presence of
GTP (10-4 M) caused a further contraction, i.e., ACh-
induced Ca2+ sensitization, in an ACh concentration-
dependent manner (Fig. 2). The ACh-induced Ca2+ sensi-
tization was significantly greater in the repeatedly OA-
challenged group (Fig. 2B).
To determine an involvement of RhoA protein in the ACh-
induced Ca2+ sensitization, the effect of pretreatment with
C3 exoenzyme on the contractile response of the α-toxin-
permeabilized BMS was also investigated. The C3 treat-
ment alone had no significant effect on the Ca2+ respon-
siveness of α-toxin-permeabilized BSMs in any groups
(data not shown). However, the ACh (10-3 M, in the pres-
ence of 10-4 M GTP)-induced Ca2+ sensitizing effect was
inhibited by treatment with C3 in both the sensitized con-
trol and OA-challenged groups (Fig. 3). Interestingly, the
remaining C3-insensitive component of the ACh-induced
Ca2+ sensitization was the same level between groups,
whereas the Ca2+ sensitization before treatment with C3
was significantly greater in BSMs of the OA-challenged
mice (Fig. 3B). These findings indicate that the C3-sensi-
tive Ca2+ sensitization, probably mediated by RhoA
[25,26], might be augmented in BSMs of the OA-chal-
lenged AHR mice.
Upregulation of RhoA protein in BSMs of OA-challenged 
mice
The expression of RhoA protein in BSM homogenates was
assessed by using immunoblotting. As shown in Fig. 4A,
immunoblotting with the antibody against RhoA gave a
single 21 kD band, indicating the expression of RhoA pro-
tein in murine BSM. The level of RhoA protein in samplesPage 4 of 11
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compared with that of the sensitized control animals.
Moreover, the GTP-bound active form of RhoA in ACh-
stimulated BSMs was markedly increased in the OA-chal-
lenged mice (Fig. 5).
Augmented ACh-induced phosphorylation of MLC in 
BSMs of OA-challenged mice
Figure 6 shows the levels of total and phosphorylated
MLCs in BSMs determined by immunoblotting and Pro-Q
Diamond dye staining, respectively. Immunoblotting
with the antibody against MLC protein revealed a single
20 kD band, which contains both phosphorylated and
non-phosphorylated MLC proteins (total MLC). The lev-
els of total MLC were the same between groups (Fig. 6,
middle panel). In the Pro-Q Diamond dye-stained gels,
there were several positive bands, i.e., phosphorylated
proteins [24], in the ACh-stimulated BSM samples.
Among them, a 20 kD band corresponding to MLC was
distinctly found (Fig. 6, bottom panel). The ACh-induced
phosphorylation of MLC in BSMs of OA-challenged mice
was markedly augmented as compared with those of
Cumulative concentration-response curves to Ca2+ of bronchial rings obtained from sensitized control (Control; open circles) and repeatedly ovalbumi -challeng d (OA-challenged; closed c rcles) miceFigure 1
Cumulative concentration-response curves to Ca2+ of bronchial rings obtained from sensitized control (Control; open circles) 
and repeatedly ovalbumin-challenged (OA-challenged; closed circles) mice. Bronchial rings were preincubated with 10-3 M acetyl-
choline (ACh) in the presence of 10-6 M nicardipine (A) or isotonic 60 mM K+ in the presence of 10-6 M atropine (B) in Ca2+-
free, 0.05 mM EGTA solution. Each point represents the mean ± S.E. from 6 experiments. The Ca2+-induced contraction of the 
ACh-stimulated bronchial smooth muscles was significantly augmented in the OA-challenged group (A; P < 0.05 by ANOVA), 
whereas no significant change in the Ca2+-induced contraction of the high K+-depolarized muscles was observed between 
groups (B).Page 5 of 11
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Acetylcholine (ACh)-induced Ca2+ sensitization of murine bronchial smooth muscle. (A) A typical recording of contraction 
induced by Ca2+ (pCa 6.0 and 5.0) and ACh (10-5–10-3 M) with guanosine triphosphate (GTP; 10-4 M) in α-toxin-permeabilized 
bronchial smooth muscle isolated from a sensitized control mouse. In the presence of GTP, ACh induced further contractions 
even in the constant Ca2+ concentration at pCa 6.0, i.e., ACh-induced Ca2+ sensitization, in an ACh-concentration-dependent 
manner. (B) Concentration-response curves for ACh (10-5–10-3 M)-induced Ca2+ sensitization in α-toxin-permeabilized bron-
chial smooth muscle isolated from sensitized control (Control; open circles) and repeatedly ovalbumin-challenged (OA-chal-
lenged; closed circles) mice. The data are expressed as percentage increase in tension induced by ACh (10-5–10-3 M) in the 
presence of Ca2+ (pCa 6.0) and GTP (10-4 M) from the sustained contraction induced by pCa 6.0. Each point represents the 
mean ± S.E. from 6 experiments. The ACh-induced Ca2+ sensitization of bronchial smooth muscle contraction was significantly 
augmented in the OA-challenged mice (*P < 0.05 vs. Control group by unpaired Student's t-test).Page 6 of 11
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Effect of Clostridium botulinum C3 exoenzyme, an inhibitor of RhoA protein, on the acetylcholine (ACh)-induced Ca2+ sensitiza-
tion of the α-toxin-permeabilized bronchial smooth muscle of mice. (A) Typical recordings of contraction induced by Ca2+ (pCa 
6.0 and 5.0) and ACh (10-3 M) with guanosine triphosphate (GTP; 10-4 M) in α-toxin-permeabilized bronchial smooth muscle 
isolated from a sensitized control mouse. In the presence of GTP, ACh induced a further contraction even in the constant Ca2+ 
concentration at pCa 6.0, i.e., ACh-induced Ca2+ sensitization (a). The ACh-induced Ca2+ sensitization was re-estimated after 
treatment with C3 exoenzyme (10 µg/mL, for 20 min; b). (B) Summary of the effects of C3 exoenzyme on the ACh-induced 
Ca2+ sensitization of bronchial smooth muscle contraction in the sensitized control (Control) and repeatedly ovalbumin (OA)-
challenged (OA-challenged) mice. The data are expressed as percentage increase in tension induced by ACh (in the presence of 
Ca2+ and GTP) from the sustained contraction induced by pCa 6.0. Each column represents the mean ± S.E. from 6 experi-
ments. *P < 0.05 vs. Control group (Before C3) and #P < 0.05 vs. respective Before C3 group by Bonferroni/Dunn's test.Page 7 of 11
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band probably corresponding to MYPT1, i.e., phosphor-
ylated MYPT1, was also found in the ACh-stimulated BSM
samples and was increased in the OA-challenged group
(data not shown).
Discussion
An in vivo AHR accompanied by increased IgE production
and pulmonary eosinophilia has been demonstrated in
the actively sensitized and repeatedly OA-challenged
BALB/c strain of mice [20]. By using the same sensitiza-
tion and challenge protocol in BALB/c mice, the current
study demonstrated an increased BSM contractility in
ACh-stimulated, but not in high K+-depolarized (without
receptors stimulation), intact muscle strips of the repeat-
edly OA-challenged mice (Fig. 1). Likewise, the ACh-
induced, C3-sensitive Ca2+ sensitization of BSM contrac-
tion was significantly augmented in α-toxin-permeabi-
lized BSMs of the OA-challenged mice (Figs. 2 and 3),
whereas the contraction induced by Ca2+ itself was the
same as the control level (see Results section). These find-
ings suggest that the C3-sensitive, RhoA-mediated Ca2+
sensitization might be augmented in BSMs of the OA-
challenged AHR mice. Indeed, the current study also dem-
onstrated a marked increase in the expression and activa-
tion of RhoA protein in BSMs of the AHR mice (Fig. 4 and
5).
In the present study, no significant difference in the Ca2+-
induced contraction (in the absence of ACh and GTP) of
α-toxin-permeabilized BSMs was observed between
groups (see Result section), indicating that the contents of
typical contractile elements such as calmodulin, myosin
light chain (MLC; Fig. 6) and SM α-actin might be the
same as control even in the BSMs of the OA-challenged
mice. Moreover, the results also indicate that the down-
stream signaling activated by Ca2+-calmodulin complex,
including phosphorylation of MLC via activation of MLC
kinase, might be in an analogous fashion between groups.
The results that the contractile response of intact (non-
permeabilized) BSMs induced by high K+ depolarization
was not changed after OA challenge also support our spec-
ulation. Thus, the baseline Ca2+ sensitivity of contractile
elements themselves in BSM cells is unlikely to change in
AHR.
By contrast with the contraction induced by Ca2+ itself, the
ACh-stimulated contraction of intact BSM strips from the
OA-challenged mice was significantly augmented as com-
pared to that from the sensitized control animals (Fig. 1).
The levels of RhoA protein in the bronchi obtained from the sensitized control (Control) and repeatedly ovalbumin (OA)-chal-lenged (OA-challenged) miceFigure 4
The levels of RhoA protein in the bronchi obtained from the sensitized control (Control) and repeatedly ovalbumin (OA)-chal-
lenged (OA-challenged) mice. (A) Typical immunoblots. Lane 1; Control, lane 2; OA-challenged, and GAPDH; glyceraldehyde-3-
phosphate dehydrogenase. The bands were analyzed by a densitometer and normalized by the intensity of corresponding 
GAPDH band, and the data are summarized in B. Each column represents the mean ± S.E. from 5 experiments. The expression 
level of RhoA protein in the bronchi was significantly increased in the OA-challenged group (*P < 0.001 vs. Control group by 
unpaired Student's t-test).Page 8 of 11
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nerves, which release ACh when stimulated leading to an
activation of muscarinic ACh receptors. The activation of
muscarinic receptors existing on BSM, which are mainly
thought to be of the M3 subtype [27], results in BSM
contraction by increasing intracellular Ca2+ concentration
through Ca2+ release from sarcoplasmic reticulum and
Ca2+ influx from voltage-dependent (nicardipine-sensi-
tive) and receptor-operated (nicardipine-insensitive) Ca2+
channels [28]. Therefore, one possible explanation for the
increased response to ACh of OA-challenged BSMs may
be attributable to an enhanced Ca2+ mobilization in BSM
cells. However, the possibility might be denied by the cur-
rent result that the ACh-induced contraction of α-toxin-
permeabilized BSMs from the OA-challenged mice was
significantly augmented as compared with that from the
control animals even at a constant Ca2+ concentration
(pCa 6.0; Fig. 2B). Moreover, it has also been reported
that there is no difference between normal and antigen-
induced AHR animals in ACh-induced increase in intrac-
ellular Ca2+ concentration in BSMs, irrespective of a great
difference in ACh-induced BSM contraction [29,30].
In addition to the classical Ca2+-mediated contractile sig-
naling in smooth muscle, it has been demonstrated that
agonist stimulation increases myofilament Ca2+ sensitiv-
ity in various types of smooth muscles including airways
[8,10,21,31]. Recent studies suggest a participation of
RhoA in the agonist-induced Ca2+ sensitization of smooth
muscle contraction [10]. Hirata et al. [32] firstly reported
an involvement of RhoA in the mechanism for the
increase in Ca2+ sensitization in smooth muscle. It was
then shown that RhoA is responsible for the inhibition of
MLC phosphatase through the activation of Rho-associ-
ated kinases [33]. The present study demonstrated an
ACh-induced Ca2+ sensitization in murine BSM contrac-
Representative immunoblots showing activation of RhoA in acetylcholine (ACh)-stimulated bro chi obtained from the sensitiz d control (Contr l) and epeatedly ovalbumin (OA)-challenged (Challenged) miceFigure 5
Representative immunoblots showing activation of RhoA in 
acetylcholine (ACh)-stimulated bronchi obtained from the 
sensitized control (Control) and repeatedly ovalbumin (OA)-
challenged (Challenged) mice. Isolated bronchial tissues were 
incubated for 10 min in the absence (-) or presence (+) of 10-
3 M ACh (see Methods). Tissues were then rapidly lysed, 
GTP-bound active form of RhoA was pulled down with GST-
tagged Rho binding domain of rhotekin, and RhoA was visual-
ized by Western blotting. The respective blot of total RhoA 
in each sample is also shown. The GTP-bound RhoA in ACh-
stimulated bronchi was markedly increased in the OA-chal-
lenged mice.
Representative photographs showing phosphorylation of myosin ligh  chain (MLC) in acetylcholine (ACh)-s imulated bronchi obtained from the ensitized control (Cont) andrepeatedly o albumin-challeng d (OA) miceFigur  6
Representative photographs showing phosphorylation of 
myosin light chain (MLC) in acetylcholine (ACh)-stimulated 
bronchi obtained from the sensitized control (Cont) and 
repeatedly ovalbumin-challenged (OA) mice. Isolated bron-
chial tissues were incubated for 10 min in the absence (non-
stimulated; NS) or presence of 10-3 M ACh (see Methods). 
The electrophoretically separated proteins on gels were 
stained by Pro-Q Diamond dye, which can detect phosphor-
ylated proteins specifically and quantitatively. After detection 
of phosphorylated proteins, immunoblotting for MLC was 
performed to detect total (phosphorylated and non-phos-
phorylated) MLC. The respective Pro-Q Diamond dye-posi-
tive band (bottom panel), which has same molecular weight 
with MLC visualized by immunoblotting (middle panel), in 
each sample was determined as phosphorylated MLC (p-
MLC). The ACh-induced phosphorylation of MLC was aug-
mented in the OA-challenged mice whereas the total MLC 
levels were equal to the control.Page 9 of 11
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in the α-toxin-permeabilized BSMs. Furthermore, western
blot analysis clearly demonstrated a distinct expression of
RhoA protein in BSMs of mice (Fig. 4). Collectively, these
findings firstly demonstrated a participation of RhoA-
mediated Ca2+ sensitization in ACh-induced BSM contrac-
tion in mice.
One of the important findings in the present study is that
the C3-sensitive, RhoA-mediated Ca2+ sensitization in
ACh-induced contraction was significantly augmented in
BSMs of the repeatedly OA-challenged AHR mice (Figs. 2
and 3). Moreover, the protein level of RhoA in BSMs of
the AHR mice was significantly increased (Fig. 4). Thus,
the current study demonstrated an augmentation of ACh-
induced, RhoA-mediated Ca2+ sensitization of BSM con-
traction, which coincides with enhanced protein
expression of RhoA, in antigen-induced AHR. Although
the mechanism(s) of up-regulation of RhoA in OA-chal-
lenged BSMs is not known here, inflammatory cytokines
such as tumor necrosis factor-α [34], which is also dem-
onstrated in airways of this murine model of asthma
(unpublished data), may be involved in. On the other
hand, it has been reported that an introduction of active
forms of RhoA to permeabilized smooth muscle induced
contractile response [32,35]. It is thus likely that ACh
stimulation activates the upregulated RhoA (Fig. 5),
resulting in a greater phosphorylation of MLC (Fig. 6) and
contraction of BSMs in AHR mice.
An increase in responsiveness to muscarinic agonists of
airway smooth muscle has been demonstrated in animal
models of AHR [21,22,36,37] and asthmatic patients [38],
although no change in the levels of plasma membrane
receptors was observed [36,37,39]. Moreover, the agonist-
induced increase in cytosolic Ca2+ level was within normal
level even in the hyperresponsive BSMs [29,30]. Taken
together with our current findings, it is likely that the
enhanced contractility to agonists reflects, at least in part,
the augmentation of muscarinic receptor- and RhoA-
mediated Ca2+ sensitization, although the mechanism(s)
for activation of RhoA by ACh is still unclear. If RhoA
proteins are activated by receptors other than muscarinic
receptor, it might account for the 'non-specific' AHR,
which is a common feature of allergic asthmatics. Indeed,
the BSMs of the OA-challenged mice also have hyperre-
sponsiveness to endothelin-1 [40], which has been
reported to activate RhoA via its own receptors [41].
An upregulation of RhoA/Rho-kinase associated with the
augmented smooth muscle contractility has also been
reported in rat myomertium during pregnancy [42,43],
arterial smooth muscle of spontaneously hypertensive
rats [12], coronary vasospasm in pigs [16], dog femoral
artery in heart failure [44], and BSMs in rat experimental
asthma [21]. Thus, the upregulation of RhoA might be
widely involved in the enhanced contraction of the dis-
eased smooth muscles including the BSMs in AHR over
species.
Conclusions
In conclusion, the current study demonstrated an ACh-
induced, RhoA-mediated Ca2+ sensitization in murine
BSM contraction. An augmentation of the Ca2+ sensitizing
effect, probably by the upregulation of RhoA protein,
might be involved in the enhanced BSM contraction
observed in the antigen-induced AHR in mice.
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